ID

33058

Description

Bone Turnover in Type 2 Diabetes Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00732121

Lien

https://clinicaltrials.gov/show/NCT00732121

Mots-clés

Versions (1)
  1. 25/11/2018 25/11/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

25 novembre 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Type 2 Diabetes NCT00732121

Anglais

Eligibility Type 2 Diabetes NCT00732121

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes treated with diet/exercise or metformin
Description

Diabetes Mellitus, Non-Insulin-Dependent | Diet therapy | Exercise | Metformin

Type de données

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0012159
UMLS CUI [3]
C0015259
UMLS CUI [4]
C0025598
hba1c less than or equal to 7%
Description

Hemoglobin A1c measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0474680
men and women aged 45-80 years old
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
if female, must be post-menopausal (natural or surgical)
Description

Postmenopausal state | Postmenopausal Surgical

Type de données

boolean

Alias
UMLS CUI [1]
C0232970
UMLS CUI [2,1]
C0232970
UMLS CUI [2,2]
C0543467
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
endocrine disorders (acromegaly, anorexia, cushings, type 2 diabetes, hyperparathyroidism, hyperthyroidism, hypercalcemia)
Description

Endocrine System Diseases | Acromegaly | Anorexia | Cushing Syndrome | Diabetes Mellitus, Non-Insulin-Dependent | Hyperparathyroidism | Hyperthyroidism | Hypercalcemia

Type de données

boolean

Alias
UMLS CUI [1]
C0014130
UMLS CUI [2]
C0001206
UMLS CUI [3]
C0003123
UMLS CUI [4]
C0010481
UMLS CUI [5]
C0011860
UMLS CUI [6]
C0020502
UMLS CUI [7]
C0020550
UMLS CUI [8]
C0020437
gi conditions (celiac sprue, gastric bypass/gastrectomy, active inflammatory bowel disease, cirrhosis)
Description

Gastrointestinal condition | Celiac Disease | Gastric Bypass | Gastrectomy | Inflammatory Bowel Diseases | Liver Cirrhosis

Type de données

boolean

Alias
UMLS CUI [1]
C4062441
UMLS CUI [2]
C0007570
UMLS CUI [3]
C0017125
UMLS CUI [4]
C0017118
UMLS CUI [5]
C0021390
UMLS CUI [6]
C0023890
cancer (including multiple myeloma) within 3 years of the study (except local non-melanoma skin cancers and cervical carcinoma in situ)
Description

Malignant Neoplasms | Multiple Myeloma | Exception Skin carcinoma Local | Exception Carcinoma in situ of uterine cervix

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0026764
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0699893
UMLS CUI [3,3]
C0205276
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0851140
active alcoholism or drug abuse
Description

Alcoholic Intoxication, Chronic | Drug abuse

Type de données

boolean

Alias
UMLS CUI [1]
C0001973
UMLS CUI [2]
C0013146
chronic kidney disease with a gfr < 60
Description

Chronic Kidney Disease | Glomerular Filtration Rate

Type de données

boolean

Alias
UMLS CUI [1]
C1561643
UMLS CUI [2]
C0017654
hiv/aids
Description

HIV Infection | AIDS

Type de données

boolean

Alias
UMLS CUI [1]
C0019693
UMLS CUI [2]
C0001175
history of hypersensitivity reaction to sitagliptin or other dpp-4 inhibitors
Description

Allergic Reaction Sitagliptin | Allergic Reaction Dipeptidyl-Peptidase IV Inhibitors

Type de données

boolean

Alias
UMLS CUI [1,1]
C1527304
UMLS CUI [1,2]
C1565750
UMLS CUI [2,1]
C1527304
UMLS CUI [2,2]
C1827106
hemoglobin < 12 mg/dl for men and < 10 for women
Description

Hemoglobin measurement | Gender

Type de données

boolean

Alias
UMLS CUI [1]
C0518015
UMLS CUI [2]
C0079399
taking medications that could affect bone turnover (estrogen, progesterone, testosterone, bisphosphonates, serms, calcitonin, teriparatide cyclosporine glucocorticoids, methotrexate or phenothiazines), thiazolidinediones, sulfonylureas, dipeptidyl peptidase-4 inhibitors, exenatide, insulin, weight loss drugs
Description

Pharmaceutical Preparations Affecting Bone remodeling | Estrogens | Progesterone | Testosterone | Diphosphonates | Selective Estrogen Receptor Modulators | Calcitonin | Teriparatide | Cyclosporine | Glucocorticoids | Methotrexate | Phenothiazines | Thiazolidinediones | Sulfonylureas | Dipeptidyl-Peptidase IV Inhibitors | exenatide | Insulin | Weight-Loss Agents

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0085268
UMLS CUI [2]
C0014939
UMLS CUI [3]
C0033308
UMLS CUI [4]
C0039601
UMLS CUI [5]
C0012544
UMLS CUI [6]
C0732611
UMLS CUI [7]
C0006668
UMLS CUI [8]
C0070093
UMLS CUI [9]
C0010592
UMLS CUI [10]
C0017710
UMLS CUI [11]
C0025677
UMLS CUI [12]
C0031436
UMLS CUI [13]
C1257987
UMLS CUI [14]
C0038766
UMLS CUI [15]
C1827106
UMLS CUI [16]
C0167117
UMLS CUI [17]
C0021641
UMLS CUI [18]
C0376606
Retour au début de la page

Similar models

Eligibility Type 2 Diabetes NCT00732121

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent | Diet therapy | Exercise | Metformin
Item
type 2 diabetes treated with diet/exercise or metformin
boolean
C0011860 (UMLS CUI [1])
C0012159 (UMLS CUI [2])
C0015259 (UMLS CUI [3])
C0025598 (UMLS CUI [4])
Hemoglobin A1c measurement
Item
hba1c less than or equal to 7%
boolean
C0474680 (UMLS CUI [1])
Age
Item
men and women aged 45-80 years old
boolean
C0001779 (UMLS CUI [1])
Postmenopausal state | Postmenopausal Surgical
Item
if female, must be post-menopausal (natural or surgical)
boolean
C0232970 (UMLS CUI [1])
C0232970 (UMLS CUI [2,1])
C0543467 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Endocrine System Diseases | Acromegaly | Anorexia | Cushing Syndrome | Diabetes Mellitus, Non-Insulin-Dependent | Hyperparathyroidism | Hyperthyroidism | Hypercalcemia
Item
endocrine disorders (acromegaly, anorexia, cushings, type 2 diabetes, hyperparathyroidism, hyperthyroidism, hypercalcemia)
boolean
C0014130 (UMLS CUI [1])
C0001206 (UMLS CUI [2])
C0003123 (UMLS CUI [3])
C0010481 (UMLS CUI [4])
C0011860 (UMLS CUI [5])
C0020502 (UMLS CUI [6])
C0020550 (UMLS CUI [7])
C0020437 (UMLS CUI [8])
Gastrointestinal condition | Celiac Disease | Gastric Bypass | Gastrectomy | Inflammatory Bowel Diseases | Liver Cirrhosis
Item
gi conditions (celiac sprue, gastric bypass/gastrectomy, active inflammatory bowel disease, cirrhosis)
boolean
C4062441 (UMLS CUI [1])
C0007570 (UMLS CUI [2])
C0017125 (UMLS CUI [3])
C0017118 (UMLS CUI [4])
C0021390 (UMLS CUI [5])
C0023890 (UMLS CUI [6])
Malignant Neoplasms | Multiple Myeloma | Exception Skin carcinoma Local | Exception Carcinoma in situ of uterine cervix
Item
cancer (including multiple myeloma) within 3 years of the study (except local non-melanoma skin cancers and cervical carcinoma in situ)
boolean
C0006826 (UMLS CUI [1])
C0026764 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0699893 (UMLS CUI [3,2])
C0205276 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0851140 (UMLS CUI [4,2])
Alcoholic Intoxication, Chronic | Drug abuse
Item
active alcoholism or drug abuse
boolean
C0001973 (UMLS CUI [1])
C0013146 (UMLS CUI [2])
Chronic Kidney Disease | Glomerular Filtration Rate
Item
chronic kidney disease with a gfr < 60
boolean
C1561643 (UMLS CUI [1])
C0017654 (UMLS CUI [2])
HIV Infection | AIDS
Item
hiv/aids
boolean
C0019693 (UMLS CUI [1])
C0001175 (UMLS CUI [2])
Allergic Reaction Sitagliptin | Allergic Reaction Dipeptidyl-Peptidase IV Inhibitors
Item
history of hypersensitivity reaction to sitagliptin or other dpp-4 inhibitors
boolean
C1527304 (UMLS CUI [1,1])
C1565750 (UMLS CUI [1,2])
C1527304 (UMLS CUI [2,1])
C1827106 (UMLS CUI [2,2])
Hemoglobin measurement | Gender
Item
hemoglobin < 12 mg/dl for men and < 10 for women
boolean
C0518015 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
Pharmaceutical Preparations Affecting Bone remodeling | Estrogens | Progesterone | Testosterone | Diphosphonates | Selective Estrogen Receptor Modulators | Calcitonin | Teriparatide | Cyclosporine | Glucocorticoids | Methotrexate | Phenothiazines | Thiazolidinediones | Sulfonylureas | Dipeptidyl-Peptidase IV Inhibitors | exenatide | Insulin | Weight-Loss Agents
Item
taking medications that could affect bone turnover (estrogen, progesterone, testosterone, bisphosphonates, serms, calcitonin, teriparatide cyclosporine glucocorticoids, methotrexate or phenothiazines), thiazolidinediones, sulfonylureas, dipeptidyl peptidase-4 inhibitors, exenatide, insulin, weight loss drugs
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0085268 (UMLS CUI [1,3])
C0014939 (UMLS CUI [2])
C0033308 (UMLS CUI [3])
C0039601 (UMLS CUI [4])
C0012544 (UMLS CUI [5])
C0732611 (UMLS CUI [6])
C0006668 (UMLS CUI [7])
C0070093 (UMLS CUI [8])
C0010592 (UMLS CUI [9])
C0017710 (UMLS CUI [10])
C0025677 (UMLS CUI [11])
C0031436 (UMLS CUI [12])
C1257987 (UMLS CUI [13])
C0038766 (UMLS CUI [14])
C1827106 (UMLS CUI [15])
C0167117 (UMLS CUI [16])
C0021641 (UMLS CUI [17])
C0376606 (UMLS CUI [18])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial